Dechra Pharmaceuticals PLC Total Voting Rights (1147T)
June 29 2018 - 9:41AM
UK Regulatory
TIDMDPH
RNS Number : 1147T
Dechra Pharmaceuticals PLC
29 June 2018
29 June 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Total Voting Rights
In conformity with DTR 5.6.1R, the Company notifies the market
of the following:
As at the date of this announcement, the Company's issued share
capital consists of 102,329,635 ordinary shares with a nominal
value of 1 pence each (Ordinary Shares), with voting rights. The
Company does not hold any Ordinary Shares in Treasury.
Therefore, the total number of Ordinary Shares with voting
rights is 102,329,635.
The above figure of 102,329,635 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change in their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Dechra Pharmaceuticals PLC
Telephone number: +44 (00 1606 814730
Email: corporate.enquiries@dechra.com
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. The majority of Dechra's
products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to
treat medical conditions for which there is no other effective
solution or have a clinical or dosing advantage over competitor
products. For more information, please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRXKLFLVQFXBBK
(END) Dow Jones Newswires
June 29, 2018 09:41 ET (13:41 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024
